They identified that Tregs from patients on HD had fewer Tregs from population II, that age did not impact the number of Tregs in this population, and there were no differences in expression of CD39, FOXP3, HLADR and CD27 by Tregs in HD and HV. This evidence concerns the gene FOXP3 and Huntington disease.